Search research articles
Contact Us
Filters
Showing results (191-200 of 203) with videos related to
Page
of 21
Sort By:
Liver International : Official Journal of the International Association for the Study of the Liver
|
July 15, 2024
High end-of-treatment hepatitis B core-related antigen levels predict hepatitis flare after stopping nucleot(s)ide analogue therapy
Simon J Hume, Danny K Wong, Man-Fung Yuen, et al.
Internal Medicine Journal
|
September 5, 2024
6-Thioguanine nucleotide levels are associated with infliximab but not adalimumab levels in inflammatory bowel disease patients on combination therapy
Natalie Yu, Tanya Lee, Daniel Tassone, et al.
Diabetes Technology & Therapeutics
|
February 14, 2022
Driving with Type 1 Diabetes: Real-World Evidence to Support Starting Glucose Level and Frequency of Monitoring During Journeys
Steven Trawley, Amanda N Stephens, Sybil A McAuley, et al.
BMJ Open
|
August 17, 2022
Study protocol: Australasian Registry of Severe Cutaneous Adverse Reactions (AUS-SCAR)
Fiona James, Michelle S Y Goh, Effie Mouhtouris, et al.
Diabetes Research and Clinical Practice
|
August 29, 2021
Meal-time glycaemia in adults with type 1 diabetes using multiple daily injections vs insulin pump therapy following carbohydrate-counting education and bolus calculator provision
Jean C Lu, Sara Vogrin, Sybil A McAuley, et al.
Diabetes Technology & Therapeutics
|
December 22, 2020
Less Nocturnal Hypoglycemia but Equivalent Time in Range Among Adults with Type 1 Diabetes Using Insulin Pumps Versus Multiple Daily Injections
Sybil A McAuley, Sara Vogrin, Melissa H Lee, et al.
Diabetes Care
|
October 15, 2020
Six Months of Hybrid Closed-Loop Versus Manual Insulin Delivery With Fingerprick Blood Glucose Monitoring in Adults With Type 1 Diabetes: A Randomized, Controlled Trial
Sybil A McAuley, Melissa H Lee, Barbora Paldus, et al.
Nature
|
October 24, 2024
Rifaximin prophylaxis causes resistance to the last-resort antibiotic daptomycin
Adrianna M Turner, Lucy Li, Ian R Monk, et al.
Internal Medicine Journal
|
November 27, 2024
Results of an Australian trial of an automated insulin delivery (AID) system and other studies support likely benefit of AID use for many Australian adults with type 1 diabetes
Alicia J Jenkins, Andrzej S Januszewski, Adrienne Kirby, et al.
BMJ Open
|
June 11, 2018
Effect of 6 months of hybrid closed-loop insulin delivery in adults with type 1 diabetes: a randomised controlled trial protocol
Sybil A McAuley, Martin I de Bock, Vijaya Sundararajan, et al.
Page
of 21
Search research articles
Search
Showing results (191-200 of 203) with videos related to
Sort By:
Page
of 21
Liver International : Official Journal of the International Association for the Study of the Liver
|
July 15, 2024
High end-of-treatment hepatitis B core-related antigen levels predict hepatitis flare after stopping nucleot(s)ide analogue therapy
Simon J Hume, Danny K Wong, Man-Fung Yuen, et al.
Internal Medicine Journal
|
September 5, 2024
6-Thioguanine nucleotide levels are associated with infliximab but not adalimumab levels in inflammatory bowel disease patients on combination therapy
Natalie Yu, Tanya Lee, Daniel Tassone, et al.
Diabetes Technology & Therapeutics
|
February 14, 2022
Driving with Type 1 Diabetes: Real-World Evidence to Support Starting Glucose Level and Frequency of Monitoring During Journeys
Steven Trawley, Amanda N Stephens, Sybil A McAuley, et al.
BMJ Open
|
August 17, 2022
Study protocol: Australasian Registry of Severe Cutaneous Adverse Reactions (AUS-SCAR)
Fiona James, Michelle S Y Goh, Effie Mouhtouris, et al.
Diabetes Research and Clinical Practice
|
August 29, 2021
Meal-time glycaemia in adults with type 1 diabetes using multiple daily injections vs insulin pump therapy following carbohydrate-counting education and bolus calculator provision
Jean C Lu, Sara Vogrin, Sybil A McAuley, et al.
Diabetes Technology & Therapeutics
|
December 22, 2020
Less Nocturnal Hypoglycemia but Equivalent Time in Range Among Adults with Type 1 Diabetes Using Insulin Pumps Versus Multiple Daily Injections
Sybil A McAuley, Sara Vogrin, Melissa H Lee, et al.
Diabetes Care
|
October 15, 2020
Six Months of Hybrid Closed-Loop Versus Manual Insulin Delivery With Fingerprick Blood Glucose Monitoring in Adults With Type 1 Diabetes: A Randomized, Controlled Trial
Sybil A McAuley, Melissa H Lee, Barbora Paldus, et al.
Nature
|
October 24, 2024
Rifaximin prophylaxis causes resistance to the last-resort antibiotic daptomycin
Adrianna M Turner, Lucy Li, Ian R Monk, et al.
Internal Medicine Journal
|
November 27, 2024
Results of an Australian trial of an automated insulin delivery (AID) system and other studies support likely benefit of AID use for many Australian adults with type 1 diabetes
Alicia J Jenkins, Andrzej S Januszewski, Adrienne Kirby, et al.
BMJ Open
|
June 11, 2018
Effect of 6 months of hybrid closed-loop insulin delivery in adults with type 1 diabetes: a randomised controlled trial protocol
Sybil A McAuley, Martin I de Bock, Vijaya Sundararajan, et al.
Page
of 21